Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Siwen Chu"'
Publikováno v:
PeerJ, Vol 9, p e12547 (2021)
Background Despite the rise in the use of immune checkpoint blockade drugs (ICBs) in recent years, there are no ICB drugs that are currently approved or under large-scale clinical trials for glioblastoma (GBM). T-cells, which mainly mediate adaptive
Externí odkaz:
https://doaj.org/article/9f403ff947b1456282e00aa560a4bf83
